Literature DB >> 8187342

T cell responses to orbital antigens in thyroid-associated ophthalmopathy.

K Arnold1, N Tandon, R S McIntosh, R Elisei, M Ludgate, A P Weetman.   

Abstract

Thyroid-associated ophthalmopathy (TAO) is most likely to be a T cell-mediated disease, in which cytokines released in the extraocular muscles activate fibroblasts, increasing glycosaminoglycan production. The nature of the orbital antigen recognized by the infiltrating T cells is unclear, although it is possible that there is cross-reactivity between this and a thyroid autoantigen to explain the close association with thyroid autoimmunity. We have tested the ability of human and porcine eye muscle antigen preparations to stimulate proliferation of circulating T cells from healthy subjects and patients with TAO or Graves' disease without clinical TAO. Occasional responses were seen, particularly after depletion of CD8+ T cells, and two out of 10 TAO patients responded to eye muscle proteins of 25-50 kD after fractionation of antigens on gels and subsequent elution. There was no disease-specific response of T cells to R1, R14, D1 and 1D3, recombinant proteins identified from screening an eye muscle cDNA library with sera from patients with autoimmune thyroid disease. We have also found that interferon-gamma (IFN-gamma) production by T cells from TAO patients was not stimulated by eye muscle membrane antigens or by 1D3. These results suggest that the frequency of circulating T cells responding to eye muscle antigens in TAO is low, and that several candidate orbital antigens, including the 64-kD protein 1D3, are unlikely to be important T cell autoantigens in this condition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8187342      PMCID: PMC1534879          DOI: 10.1111/j.1365-2249.1994.tb06562.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy.

Authors:  A P Weetman; P Fells; B Shine
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

2.  T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes.

Authors:  B O Roep; A A Kallan; W L Hazenbos; G J Bruining; E M Bailyes; S D Arden; J C Hutton; R R de Vries
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

3.  Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease.

Authors:  P V Ross; R J Koenig; P Arscott; M Ludgate; M Waier; C C Nelson; M M Kaplan; J R Baker
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

4.  Thyroid autoantigens and human T cell responses.

Authors:  N Fukuma; S M McLachlan; B Rapoport; J Goodacre; S L Middleton; D I Phillips; C A Pegg; B Rees Smith
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease.

Authors:  Q Dong; M Ludgate; G Vassart
Journal:  J Clin Endocrinol Metab       Date:  1991-06       Impact factor: 5.958

6.  Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy.

Authors:  R A Metcalfe; A P Weetman
Journal:  Clin Endocrinol (Oxf)       Date:  1994-01       Impact factor: 3.478

7.  Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts.

Authors:  T J Smith; R S Bahn; C A Gorman; M Cheavens
Journal:  J Clin Endocrinol Metab       Date:  1991-05       Impact factor: 5.958

8.  Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities.

Authors:  M Salvi; Z G Zhang; D Haegert; M Woo; A Liberman; L Cadarso; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

9.  Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy.

Authors:  M de Carli; M M D'Elios; S Mariotti; C Marcocci; A Pinchera; M Ricci; S Romagnani; G del Prete
Journal:  J Clin Endocrinol Metab       Date:  1993-11       Impact factor: 5.958

10.  Pathogenesis of thyroid-associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis.

Authors:  J R Wall; N Bernard; A Boucher; M Salvi; Z G Zhang; J Kennerdell; A Tyutyunikov; C Genovese
Journal:  Clin Immunol Immunopathol       Date:  1993-07
View more
  6 in total

1.  Significance of serum antibodies reactive with flavoprotein subunit of succinate dehydrogenase in thyroid associated orbitopathy.

Authors:  B M Hosal; J K Swanson; C R Thompson; S Kubota; K Gunji; J S Kennerdell; J R Wall
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

Review 2.  Thyroid eye disease.

Authors:  D H Char
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

Review 3.  Pathogenesis of ophthalmopathy in autoimmune thyroid disease.

Authors:  A E Heufelder
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

4.  Analysis of orbital T cells in thyroid-associated ophthalmopathy.

Authors:  G Förster; E Otto; C Hansen; K Ochs; G Kahaly
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

5.  Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopathy.

Authors:  J Kiljanski; C Stolarski; A Barsouk; V Nebes; J R Wall
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

Review 6.  Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.

Authors:  Sijie Fang; Yi Lu; Yazhuo Huang; Huifang Zhou; Xianqun Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.